Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 7,813.4%.

ASSET	% RETURN
Regencell Bioscience (RGC)	7,813.39%
Janover Inc Common Stock (JNVR)	1,810.62%
Asset Entities Inc Class B Common Stock (ASST)	1,274%
Kindly MD, Inc Common Stock (KDLY)	1,017.74%
Oncology Institute (TOI)	893.46%
Moolec Science SA Ordinary Shares (MLEC)	842.4%
Global Interactive Technologies (GITS)	543.15%
Dominari (DOMH)	495.73%
Nutex Health (NUTX)	442.49%
Abits (ABTS)	401.57%
Regulus Therapeutics (RGLS)	390.63%
ThredUp (TDUP)	375.69%
Oriental Culture Holding (OCG)	357.14%
Yoshiharu Global (YOSH)	329.09%
Mobile-health Network Solutions Class A Ordinary Shares (MNDR)	300.12%
FingerMotion (FNGR)	266.13%
Curiositystream (CURI)	261.29%
CervoMed (CRVO)	260%
Aeva Technologies, Inc Common Stock (AEVA)	250.41%
VivoPower International (VVPR)	243.7%
DBV Technologies (DBVT)	242.25%
Rapid Micro Biosystems (RPID)	236.26%
QuantaSing Group Limited American Depositary Shares (QSG)	233.48%
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP)	228.2%
NETCLASS TECHNOLOGY INC Class A Ordinary Shares (NTCL)	228.08%